Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs

1998 ◽  
Vol 82 (5) ◽  
pp. 589-593 ◽  
Author(s):  
MuraliN Bathina ◽  
Steve Mickelsen ◽  
Conni Brooks ◽  
Joe Jaramillo ◽  
Trish Hepton ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Catheter Ablation ◽  
Supraventricular Tachycardia ◽  
Medical Therapy ◽  
Initial Treatment ◽  
Healthcare Costs ◽  
Radiofrequency Catheter Ablation

scholarly journals Modern treatment of supraventricular tachycardia

2020 ◽  
Vol 19 (5) ◽  
pp. 2694
Author(s):  
A. I. Tarzimanova ◽  
V. I. Podzolkov
Keyword(s):  
Quality Of Life ◽  
Cardiovascular Disease ◽  
Catheter Ablation ◽  
General Population ◽  
Supraventricular Tachycardia ◽  
Antiarrhythmic Therapy ◽  
High Effectiveness ◽  
Modern Treatment ◽  
The Stability

Supraventricular tachycardia (SVT) is one of the most common arrhythmias. The prevalence of SVT varies widely in different countries and is 2,25 per 1,000 people in the general population. SVT reduce the quality of life of patients, and in some cases can worsen the prognosis. In patients with cardiovascular disease, the risk of SVT increases. Therapy of SVT is selected depending on the stability of hemodynamic and the QRS width. Until now, the treatment of SVT remains an urgent issue of modern cardiology, since despite the high effectiveness of catheter ablation, antiarrhythmic therapy plays an important role.

Sign in / Sign up

Export Citation Format

Share Document